regenerative-medicine
Following last year's success, Prof. Tremolada returns to Warsaw for the world congress. Most treatments used for degenerative diseases are unable to maintain full joint functionality and physical fitness in patients. Due to the continuous increase in these conditions, physicians worldwide are seeking effective alternative treatments. New therapies should be capable of reducing patient pain and extending physical activity. The conference is led by world-renowned experts - physicians and scientists including Prof. Carlo Tremolada - who are leaders in research, development, and application of new technologies for treating degenerative diseases and traumas that lead to their development.
Mesenchymal stem cells assist in healing from trauma and injuries, and Lipogems is the most efficient, rapid, and safe system for supporting recovery and healing by naturally delivering them to the site through autologous adipose tissue transplantation. Patients with articular cartilage lesions may experience joint pain and reduced functionality, often progressing to end-stage osteoarthritis, which is among the top 10 causes of disability worldwide.
Lipogems accelerates the natural tissue regeneration and repair process by preserving adipose tissue integrity and its vascular network. The system gently processes autologous adipose tissue while maintaining its biological and structural properties. This technology enables conservative treatment of various degenerative joint conditions including shoulder, knee, ankle, and hip, offering a minimally invasive therapeutic alternative.